Down‐regulation of the TGF‐β and NF‐κB pathways contributed to the inhibition of EMT and might be the cause of the improved anti‐metastatic activity of DSF/Cu in HCC. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.